[Click eStock] "Incredible Buzz Growing into a Global Medical Device Platform Company"

On August 12, independent research firm Aris analyzed that Incredible Buzz is accelerating its entry into the healthcare industry and is growing into a global medical device platform company. The firm did not provide an investment opinion or target price.

Jaemo Lee, a researcher at Aris, evaluated, "Incredible Buzz is a company with a differentiated product marketing strategy and a structurally sound profit model centered on new businesses, based on its successful experience in the domestic market with the global brand 'Motiva.'"

He further explained, "The company is supplying amino acid-based beauty and medical products through its collaboration with Italy's Professional Dietetics."

The company's flagship product, the biostimulator 'Sunekos,' contains hyaluronic acid (HA) and a combination of six amino acids (HY6AA) as its main ingredients. The company has secured exclusive distribution rights for Asia, including South Korea, and the Americas, and is aiming to obtain domestic product approval from the Ministry of Food and Drug Safety in the fourth quarter of this year.

Researcher Lee stated, "After achieving success in the domestic market, the company plans to expand its distribution channels to major Asian countries such as Singapore, Malaysia, Thailand, and Taiwan," and emphasized, "We expect a full-fledged turnaround, beginning with the domestic and overseas distribution of Sunekos."

He added, "By operating the beauty finance platform 'Gangnam Oppa' through its subsidiary Incredible Daebu, the company will strengthen synergies with its existing medical device distribution business and expand its stable cash generation base."

This content was produced with the assistance of AI translation services.